ReviewFrontiers in aging neuroscience2025
Beyond the auditory system: cognitive implications of age-related hearing loss.
Review in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neurovascular-metabolic coupling links hearing loss to cognitive impairment: Evidence from GABA and cerebral blood flow in presbycusis.Neurobiology of disease · 2026Article
- Effects of Hearing Intervention on Cognitive Function in Patients with Presbycusis: A Systematic Review and Meta-Analysis.Audiology research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Age-related hearing loss (ARHL) is one of the most common causes of disability in older adults. It is also frequently associated with neurological and neurodegenerative disorders, including dementia, as well as with stress, anxiety, depression, and social isolation. These observations suggest that ARHL should be considered not merely as a sensory dysfunction, but rather as a complex disease involving extra-auditory domains. Namely, identifying shared pathogenic determinants between hearing loss and neurodegenerative diseases remains a significant challenge. Increasing research in this field has highlighted common molecular mechanisms underlying age-related hearing and cognitive vulnerability, as well as potential overlapping neuronal networks involved in both cognitive and auditory neurodegeneration. In this review, we first outline the clinical features, risk factors, and molecular pathways involved in ARHL. We then examine the molecular mechanisms underlying ARHL at both peripheral (cochlea) and central level (auditory cortex), and subsequently discuss the cognitive comorbidities of ARHL, with a particular focus on cognitive impairment and affective disorders. From a translational point of view, exploring the extra-auditory consequences of ARHL will be crucial, as it will enable the identification of risk factors for both auditory and cognitive vulnerability and support the development of effective therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.